Latest News in the pharma Industry

All

Native Antigen Company expands into new development and production facilities

Native Antigen Company expands into new development and production facilities

2 May 2017

Expansion doubles manufacturing capacity and includes the introduction of new facilities.

Read more 
AstraZeneca’s Imfinzi receives FDA accelerated approval for previously treated patients with advanced bladder cancer

AstraZeneca’s Imfinzi receives FDA accelerated approval for previously treated patients with advanced bladder cancer

2 May 2017

Imfinzi is the cornerstone in an extensive immuno-oncology program across multiple cancer types and stages of disease.

Read more 
Concert Pharmaceuticals initiates CTP-543 Phase II trial in alopecia areata

Concert Pharmaceuticals initiates CTP-543 Phase II trial in alopecia areata

2 May 2017

Trial designed to evaluate the safety and efficacy of CTP-543 after 12 months of dosing with the primary efficacy analysis at week 24.

Read more 
GSK invests $139 million to expand production capacity for Benlysta in Rockville

GSK invests $139 million to expand production capacity for Benlysta in Rockville

1 May 2017

Site is also expected to house production of a new subcutaneous form of belimumab, which is currently under review with the FDA.

Read more 
Shire and Parion Sciences sign collaborative license agreement to advance P-321 for ophthalmic indications

Shire and Parion Sciences sign collaborative license agreement to advance P-321 for ophthalmic indications

1 May 2017

P-321 is a Phase II investigational topical treatment for dry eye disease.

Read more 
Impax announces FDA approval and launch of a generic version of Vytorin

Impax announces FDA approval and launch of a generic version of Vytorin

1 May 2017

One of the first companies to offer a generic version of Vytorin.

Read more 
Takeda announces FDA Accelerated Approval of Alunbrig

Takeda announces FDA Accelerated Approval of Alunbrig

30 Apr 2017

Alunbrig approved for ALK+ metastatic non-small Cell lung cancer patients who have progressed on or are intolerant to crizotinib.

Read more 
China FDA approves country’s first all-oral regimen for chronic hepatitis C, Daklinza in combination with Sunvepra

China FDA approves country’s first all-oral regimen for chronic hepatitis C, Daklinza in combination with Sunvepra

28 Apr 2017

Daklinza and Sunvepra combination approved for genotype 1b, the most common chronic hepatitis C (HCV) genotype in China; combination has a 91-99% cure rate.

Read more 
Sartorius introduces new BIOSTAT STR bioreactor range and new Flexsafe STR single-use bags

Sartorius introduces new BIOSTAT STR bioreactor range and new Flexsafe STR single-use bags

28 Apr 2017

New generation of bioreactors combined with new Flexsafe STR bags offer a fully scalable, single-use system.

Read more 
Allergan successfully completes ZELTIQ Aesthetics acquisition

Allergan successfully completes ZELTIQ Aesthetics acquisition

28 Apr 2017

Acquisition adds best-in-class body contouring business to Allergan's facial aesthetics, plastic surgery and regenerative medicine businesses.

Read more 
Record growth for life science tech firm as MES adoption increases globally

Record growth for life science tech firm as MES adoption increases globally

27 Apr 2017

Zenith Technologies surpasses the €20 million milestone for sales of its manufacturing execution system (MES) services.

Read more 
Learn from change-making pharmaceutical leaders: CPhI North America keynote speakers announced

Learn from change-making pharmaceutical leaders: CPhI North America keynote speakers announced

27 Apr 2017

CPhI North America will feature the first-ever Connect Conference.

Read more